Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03 - Concepedia

Concepedia

Publication | Closed Access

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

10

Citations

19

References

2023

Year

Jesús García-Donás, Alicia Hurtado, Laia Garrigós, Ana Santaballa, Andrés Redondo, Laura Vidal, Núria Laínez, Eva Guerra, Víctor M. Rodríguez, Juan Cueva,

Clinical & Translational Oncology

References

	Year	Citations

Page 1